Cargando…
Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug
Gabapentin (GBP), an antiepileptic and anti-neuropathic agent, suffers from short half-life (5–7 h), has narrow absorption window, and is absorbed via carrier-mediated mechanism resulting in frequent dosing, poor compliance, and poor bioavailability (<60%). Moreover, GBP is a freely water-soluble...
Autores principales: | Abouelatta, Samar M., Aboelwafa, Ahmed A., El-Gazayerly, Omaima N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058684/ https://www.ncbi.nlm.nih.gov/pubmed/29792353 http://dx.doi.org/10.1080/10717544.2018.1474969 |
Ejemplares similares
-
Natural gums as sustained release carriers: development of gastroretentive drug delivery system of ziprasidone HCl
por: AJ, Rajamma, et al.
Publicado: (2012) -
Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl
por: El Nabarawi, Mohamed A, et al.
Publicado: (2017) -
Enhancement of Oral Bioavailability of Ibandronate Through Gastroretentive Raft Forming Drug Delivery System: In Vitro and In Vivo Evaluation
por: Hanif, Muhammad, et al.
Publicado: (2020) -
Cubosomal Betamethasone-Salicylic Acid Nano Drug Delivery System for Enhanced Management of Scalp Psoriasis
por: Shalaby, Rodayna Atef, et al.
Publicado: (2022) -
Superhydrophobic Substrates for Ultrahigh Encapsulation of Hydrophilic Drug into Controlled-Release Polyelectrolyte Complex Beads: Statistical Optimization and In Vivo Evaluation
por: Yousry, Carol, et al.
Publicado: (2019)